Trends in Endocrinology & Metabolism
ReviewInsights into amylin–leptin synergy
Section snippets
Leptin ‘resistance’ in obesity
Body weight homeostasis is a multi-factorial dynamic process that requires the central integration of peripheral signals of energy stores with physiological or behavioral responses 1, 2, 3. In general, these peripheral signals include gastric peptides (cholecystokinin, peptide YY, ghrelin, bombesin) that act as short-term regulators of satiation and feeding behavior, and longer-term signals of energy balance such as insulin. Recently, adipose tissue has emerged as an active endocrine organ that
Leptin ‘sensitivity’ in obesity
Although there are gaps in our understanding of the temporal relationship between hyperleptinemia, leptin resistance and the development or maintenance of obesity, clearly a reduction in plasma leptin (experienced during states of prolonged underfeeding or starvation) is a relevant and potent physiological signal related to energy balance regulation, rather than increased leptin in states of weight gain [28]. The ‘leptin sensitivity threshold’ concept proposed by Leibel contends that an
Amylin acts synergistically with leptin to reduce body weight in obesity
Amylin is secreted from pancreatic β-cells in proportion to insulin and has multiple physiological roles, notably as a satiogenic signal, an inhibitor of gastric emptying and a glucoregulatory molecule. The physiological effects of peripheral amylin are almost solely mediated via interaction with its receptor in the area postrema (AP) of the brain stem [30]. Areas downstream of the AP, including the nucleus of the solitary tract (NTS), the lateral parabrachial nucleus and the central nucleus of
Is there a ‘sweet spot’ for synergy?
Recent clinical findings established clear proof-of-concept for combined amylin and leptin agonism leading to greater weight loss than either treatment alone. First, in a 24-week randomized, double-blind clinical proof-of-concept study in overweight or obese subjects (BMI 27–35 kg/m2) following 4 weeks of pre-treatment with pramlintide (an amylin agonist), co-administration of methionyl recombinant human leptin (metreleptin) and pramlintide elicited significant weight loss of ∼13% compared with
Hypothalamic and extra-hypothalamic regions
Although the pharmacology of amylin and leptin in different degrees of leptin resistance deserves further investigation, neurobiological mechanistic studies mapping circuits of activated neurons in lean, obese and amylin knockout animals have revealed several notable cooperative central interactions. In brief, in lean rats, acute central leptin increased the food-intake-inhibitory effects of peripherally administered amylin [37]. There are also several lines of evidence supporting a critical
Neurobiological studies
Clearly, further neurobiological studies into the mechanisms and neural pathways recruited by amylin–leptin are warranted. Clarification of the phenotype and projection fields of neurons in which amylin restores or enhances leptin signaling could yield important insights into critical regions involved in overcoming leptin resistance. The VMH has emerged as a consistent candidate region in several of our studies 34, 41 and VMH signals such as histamine play an important role in the individual
Summary
Exogenous pharmacological amylin synergizes with leptin to induce marked and sustained fat-specific body weight loss in DIO rats. Clinical weight loss studies with combined pramlintide and metreleptin agonism confirm an interaction between these two signaling systems and have identified sub-populations (encompassing a majority of overweight or obese patients) that might be particularly responsive. Although there are limitations in terms of the availability and applicability of extant molecular
Disclosure statement
J.L.T., D.G.P. and J.D.R. are employed by and own stock in Amylin Pharmaceuticals, Inc.
Acknowledgements
The authors gratefully acknowledge Mary Erickson and Jean Chan for helpful comments and discussion during preparation of this review.
References (59)
- et al.
The adipocyte as an active participant in energy balance and metabolism
Gastroenterology
(2007) Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity
J. Biol. Chem.
(2004)The geometry of leptin action in the brain: more complicated than a simple ARC
Cell Metab.
(2009)Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice
Cell Metab.
(2005)Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells
Cell Metab.
(2006)Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat
Neurosci. Lett.
(2003)Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin
Physiol. Behav.
(2007)Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?
Physiol. Behav.
(2010)Leptin amplifies the feeding inhibition and neural activation arising from a gastric nutrient preload
Physiol. Behav.
(2001)Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation
Cell Metab.
(2010)